Article and Video CATEGORIES

Cancer Journey

Search By

Raquel’s journey into yoga began in 2005 while living in New York.  As a leader of teams in Oncology Pharmaceuticals, Raquel wanted to be better at interacting, supporting, and developing people and knew that one way to make serious change in her life would be to embrace yoga and all its philosophies. 

GRACE & Living Yoga Therapy Partnership ~ a Wonderful Thing
dbrock
Author
Raquel Jex Forsgren, Yoga Therapist, C-IAYT
Image

GRACE and Living Yoga Therapy continue to provide more in our series on surviving with cancer.  

Our friend and partner, Raquel Jex Forsgren, founder of Living Yoga Therapy based in Chicago continues to bring us wonderful tips and yoga techniques for dealing with cancer.  

Raquel has provided GRACE with helpful videos targeted for the cancer community, and dealing with the stresses and strains of a cancer journey. 

We invite you to visit our partner page for the list of videos provided by Raquel, and if you have questions please feel free to ask in our community forums

 

 

 


 

 
Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)

There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...

Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.

The...

Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...

Hi Stan!  So good to hear from you.  I'm sorry for the late response.  I too have been out of town with family and missed your post, probably because I was...

It is so good to hear from you!  And I am so happy to hear that your holidays have been good and that you are doing well.  It sounds like your...

Recent Comments

JOIN THE CONVERSATION
Biomarkers
By JanineT GRACE … on
Radiation Therapy
By JanineT GRACE … on
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
Hi Stan!! and happiest of holidays!
By dbrock on